Roche Holding Ltd ADR (RHO6y)

40.865
+0.595(+1.48%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    40.380 - 40.865

RHO6y Overview

Prev. Close
40.27
Day's Range
40.38-40.865
Revenue
65.02B
Open
40.38
52 wk Range
35.935-49.48
EPS
17.85
Volume
0
Market Cap
269.53B
Dividend (Yield)
0.7765
(1.89%)
Average Volume (3m)
253
P/E Ratio
17.67
Beta
0.297
1-Year Change
-6.78%
Shares Outstanding
801,094,291
Next Earnings Date
-
What is your sentiment on Roche Holding ADR?
or
Vote to see community's results!

Roche Holding Ltd ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Roche Holding Ltd ADR Analysis

Roche Holding Ltd ADR Company Profile

Roche Holding Ltd ADR Company Profile

Employees
100920
  • Type:Equity
  • Market:Germany
  • ISIN:US7711951043
  • WKN:891106

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsBuyBuyBuyStrong BuyNeutral
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral